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Background: Peritoneal insufflation results in hemodynamic changes during laparoscopic cholecystectomy.
The aim of the present work is to test whether non-invasive applanation tonometry is suitable for reflecting
these hemodynamic alterations.
Methods: 41 patients undergoing laparoscopic cholecystectomies were monitored using the SphygmoCor pulse
wave analysing system. Peripheral blood pressures (PBP), central aortic blood pressures (CBP), augmentation index
(ALX@HR75) and subendocardial viability ratio (SVR) were measured at rest (Phase 1), after anesthetic induction
(Phase 2), after peritoneal inflation (Phase 3) and after peritoneal deflation (Phase 4).
Results: Induction of anesthesia resulted in a statistically significant reduction in both the peripheral blood pressure
and central aortic pressures, accompanied by a decrease in augmentation pressure and augmentation index.
Peripheral blood pressures did not change along with the peritoneal cavity insufflation, except for a moderate
increase in systolic blood pressure. In contrast to this, an increase could be observed in central aortic pressure
(106.77 ± 18.78 vs. 118.05 ± 19.85 mmHg, P < 0.01) which was accompanied by increased augementation pressure
(18.97 ± 10.80 vs. 31.55 ± 12.01; P < 0.001) and augmentation index (7.31 ± 5.59 vs. 12.61 ± 7.56, P < 0.001), indicating
a rise in peripheral arterial stiffness.
Conclusions: The Sphigmocor pulse wave analysis system can be reliably used for detecting and monitoring
cardiovascular changes occurring during laparoscopic cholecystectomy.
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It has been proven by previous studies that inducing a
positive pressure within the intraperitoneal cavity during
laparoscopic surgical interventions results in numerous
cardiovascular, neuroendocrine and renal changes [1].
These changes include an increase in systemic and pulmon-
ary vascular resistance and a consequent decrease in car-
diac output, which may be attributed to direct mechanical* Correspondence: fulesdi@med.unideb.hu
1Department of Anesthesiology and Intensive Care, University of Debrecen,
Medical and Health Science Centre, Nagyerdei krt. 98, H-4032 Debrecen,
Hungary
Full list of author information is available at the end of the article
© 2014 Sárkány et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.factors due to intraperitoneal pressure rise as well as to
humoral changes evoked by the procedure [2].
During preoperative anesthesiological consultation it is
a frequent question whether laparoscopic cholecystectomy
can be performed safely in patients with known cardiovas-
cular risk factors. It is worth mentioning that in a study of
low risk patients undergoing laparoscopic cholecystec-
tomy, 2 out of 16 patients had acute ST changes on their
ECG [3]. In view of this, preoperative cardiovascular risk
stratification as well as proper intraoperative monitoring
may be of high importance in patients at risk.
So far, cardiovascular consequences occurring during
laparoscopic procedures have been assessed either during
animal experiments [4] or by using invasive intraoperativel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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invasive hemodynamic monitoring techniques may also
have side effects and thus are not indicated in all patients
undergoing otherwise relatively short and low risk surgical
procedures.
Along these lines, we tested the hypothesis that cardio-
vascular changes caused by CO2-pneumoperitoneum may
be accurately assessed intraoperatively by non-invasive
applanation tonometry. Our results were compared with
data obtained from the literature.Patients and methods
Patients
A total of 41 consecutive patients undergoing elective
laparoscopic cholecystectomy for symptomatic cholelithia-
sis without cholangiography or choledochotomy were
enrolled in this prospective case-series. The patients were
all in good health, classified as ASA I and II. This study
was conducted with approval from the University of
Debrecen Medical Ethics Committee (Registration number:
DEOEC RKET/IKET 2312-2010, responsible person: József
Szentmiklósi; Department of Pharmacology, University
of Debrecen, 98.Nagyerdei krt. Debrecen, Hungary,
Phone: +3652411600). A written informed consent to
participate was obtained from all patients included in
the study. Patients with diabetes mellitus, untreated
hypertension, atrial fibrillation, morbid obesity (body
mass index [BMI] > 35), infection, psychiatric or neuro-
logic conditions impairing patients’ ability to cooperate
were excluded from the study.Anesthesia and CO2 pneumoperitoneum
General anesthesia was administered to all patients
according to the same protocol. During the patient’s stay
in the preparation area, 15 ml/kg/BW of Ringer’s acetate
solution was infused for a period of 2 hours. As premedica-
tion, oral midazolam (0.15 mg/kgBW) was administered
30 minutes before the induction of anaesthesia. Following
preoxygenation (2 minutes) by face mask, anesthesia was
induced with intravenous propofol (2 mg/kg BW) and
fentanyl (3-5 μg/kgBW). Rocuronium 0.6 mg/kgBW was
used to facilitate tracheal intubation and maintain muscle
relaxation. After intubation, the lungs were ventilated with
a mixture of air/oxygen (50/50%). For maintenance of
anesthesia sevoflurane (2 vol%) and intermittent doses of
fentanyl were applied. Sevoflurane was titrated in order to
keep the bispectral index (BIS) values between 40 and 50.
Ventilation was mechanically controlled at a frequency and
tidal volume sufficient for maintaining normocapnia. PEEP
was not administered (ZEEP). End expiratory CO2 was
used to ensure normoventilation (end-tidal carbon dioxide
level was kept between 35 and 38 mmHg). Intraoperative
crystalloid infusion was administered at 7 mL/kg per hour.During anesthesia body temperature was maintained
between 36,0 and 36,5°C by heating blankets.
The surgical technique was similar for all patients. CO2
intraperitoneal pressure was maintained automatically at a
recommended 12-14 mmHg by a CO2 insufflator at an
insufflation rate of 1 to 1,5 L/min with the patients placed
in the 20° reverse Trendelenburg position (rT). On
confirming the appropriate placement of the video laparo-
scope, each patient’s position was changed to a left lateral
tilt (10°-15°). Once the surgery was completed, the abdo-
men was deflated and each patient was returned to the
horizontal position.
Routine intraoperative patient monitoring included
continuous five-lead electrocardiography, pulse oximetry,
non-invasive blood pressure measurements, peak airway
pressures, capnography, as well as BIS monitoring for
assessment of depth of anesthesia. Neuromuscular moni-
toring was performed to control the neuromuscular block
throughout the course of anesthesia using TOF Watch SX
acceleromyograph.
Monitoring cardiovascular function
The SphygmoCor pulse wave analysing system was used
for monitoring cardiovascular function, which is a non-
invasive method based on applanation tonometry [10].
During the present study we measured systemic and
central aortic pressure, augmentation pressure, augmenta-
tion index, ejection duration and subendocardial viability
ratio.
 Measurement of central aortic pressure and aortic
pressure waveform: A conventional cuff pressure
measurement was used for calibration. After
applanation tonometry SphygmoCor derived a
complete waveform for the whole cardiac cycle for
the aortic pulse. A combination of the two methods
makes it possible to analyse the coupling between
the ejecting heart and the pressure load.
 Measurement of augmentation pressure and
augmentation index: Augmentation pressure is
based on the principle that there is a reflected
pressure from the periphery that appears in the
aortic pressure waveform. The amount of
augmentation reflects the stiffness of the peripheral
arterial tree: it increases along with higher stiffness.
In order to make the value of augmentation index
independent from the individual changes of pulse
rate, the device calculates a corrected augmentation
index (ALX@HR75).
 Subendocardial viability ratio: This parameter is
calculated by the device by dividing the area under
the systolic and diastolic part of the curve. A ratio
under 100% reflects underperfusion of the
subendocardium.
Sárkány et al. BMC Anesthesiology 2014, 14:98 Page 3 of 7
http://www.biomedcentral.com/1471-2253/14/98Hemodynamic measurements were repeated in different
phases of the procedure: Before induction of anesthesia
(resting phase, Time 1); 5 minutes after induction of
anesthesia (Time 2.); 5 minutes after inflation of the peri-
toneal space (Time 3.) followed by repeated measure-
ments every 10 minutes and 5 minutes after deflation of
the peritoneal cavity (Time 4).Statistical analysis
Means and standard deviation were calculated for all
values. Repeated measure analysis of variance was used
for all values to check the time main effect of the laparo-
scopic procedure, i.e. whether laparoscopic cholecystec-
tomy overall had any significant hemodynamic effect.
Pairwise comparisons of all parameters were performed in
order to check the effect of inflation and deflation of the
peritoneal space by taking the values obtained after induc-
tion of anesthesia as reference value. A p < 0.05 was con-
sidered as a statistically significant difference.Results
A total of 41 patients entered the study. There were 33 fe-
males and 8 males with an average age of 52.3 ± 15.4 years.The effect of anesthetic induction on hemodynamic
parameters
As shown in Table 1, induction of anesthesia resulted in a
statistically significant reduction in both peripheral blood
pressure and central aortic pressures, accompanied by a
decrease in augmentation pressure and augmentation




Systolic 132.47 ± 18.87
Diastolic 78.60 ± 10.40
Pulse pressure 52.12 ± 16.12
Central (aortic) b
Systolic 120.80 ± 19.10
Diastolic 80.00 ± 10.38
Pulse pressure 41.05 ± 14.70
Ejection duration 41.0 ± 4.93
Pressure aug
Augmentation pressure 10.52 ± 8.52
Augmentation index 23.62 ± 10.58
Subendocardial viability ratio (%) 121.85 ± 22.7
Means and standard deviations are shown.The effect of peritoneal insufflation on hemodynamic
parameters
Table 2 summarizes the parameters that were obtained be-
fore and after peritoneal cavity insufflation. Peripheral
blood pressures did not change markedly along with peri-
toneal cavity insufflation, except for a moderate increase
in systolic blood pressure. In contrast to this, a marked in-
crease could be observed in central aortic pressure values
which was accompanied by increased augementation
pressure and augmentation index, indicating a rise in
peripheral arterial stiffness. Despite changes in the central
aortic blood pressure, subendocardial viability ratio re
mained relatively stable during and after peritoneal cavity
insufflation.
Comparison of hemodynamic parameters at
preeinduction and peritoneal insufflation phase
Peripheral and central blood pressures returned to the pre-
induction values after peritoneal insufflation (comparison
of Phase 1 and 3). The only parameter that showed a grad-
ual increase was augmentation index (Table 3).
After deflation of the abdominal cavity both peripheral
and aortic pressure values returned to the levels observed
after induction of anesthesia. Although augmentation
pressures were still higher than before inflation, augmen-
tation index (the main indicator of peripheral arterial stiff-
ness) also returned to the pre-insufflation value. Figure 1
depicts and summarizes the changes of all parameters
during the entire course of the study.
Discussion
In this cohort study we used a new non-invasive technique
for assessing the cardiovascular changes that occur during
laparoscopic cholecystectomy, the Sphigmocor pulse wavecentral (aortic) blood pressures, ejection duration and
After induction p-value
d pressure
116.80 ± 18.61 P < 0.001
72.71 ± 13.54 0.01
43.65 ± 11.96 P < 0.01
lood pressure
106.77 ± 18.78 P < 0.001
73.88 ± 13.79 P < 0.01
33.11 ± 11.08 P < 0.001
38.40 ± 6.71 0.01
mentation
7.31 ± 5.59 P < 0.01
18.97 ± 10.80 P < 0.01
142.5 ± 38.2 P < 0.01
Table 2 The effect of peritoneal cavity insufflation on peripheral and central (aortic) blood pressures, ejection duration
and pressure augmentation
Before insufflation After insufflation p-value
Peripheral blood pressure
Systolic 116.80 ± 18.61 125.17 ± 20.21 0.02
Diastolic 72.71 ± 13.54 78.92 ± 16.94 0.07
Pulse pressure 43.65 ± 11.96 44.64 ± 13.23 0.24
Central (aortic) blood pressure
Systolic 106.77 ± 18.78 118.05 ± 19.85 P < 0.01
Diastolic 73.88 ± 13.79 81.82 ± 12.28 P < 0.01
Pulse pressure 33.11 ± 11.08 36.41 ± 12.60 0.04
Ejection duration 38.40 ± 6.71 39.15 ± 5.51 0.34
Pressure augmentation
Augmentation pressure 7.31 ± 5,59 12.61 ± 7.56 P < 0.001
Augmentation index 18.97 ± 10.80 31.55 ± 12.01 P < 0.001
Subendocardial viability ratio (%) 142.5 ± 38.2 137.11 ± 26.3 P = 0.48
Means and standard deviations are shown.
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clinical conditions such as arterial hypertension, diabetes
mellitus, systolic heart failure and preeclampsia [11-13]. In
anesthesiological practice, this is the first report on the use
of the technique.
Similar to previous reports we were able to detect a sig-
nificant decline of the systemic blood pressure after
anesthetic induction which was accompanied by a de-
crease in augmentation index, reflecting the stiffness of
the peripheral vessels [3,5,9,14,15]. This initial reduction
in blood pressure and peripheral resistance may be due to
the direct myocardial depressant and vasodilatory effects
of the anesthetics together with the loss of sympathetic
tone [2]. During the next phase of the procedure, afterTable 3 Comparison of peripheral and central (aortic) blood p
values at phases before induction and after peritoneal insuff
Before induction
Peripheral bloo
Systolic 132.47 ± 18.87
Diastolic 78.60 ± 10.40
Pulse pressure 52.12 ± 16.12
Central (aortic) b
Systolic 120.80 ± 19.10
Diastolic 80.00 ± 10.38
Pulse pressure 41.05 ± 14.70
Ejection duration 41.0 ± 4.93
Pressure aug
Augmentation pressure 10.52 ± 8.52
Augmentation index 23.62 ± 10.58
Subendocardial viability ratio (%) 121.85 ± 22.7
Means and standard deviations are shown.inflating the abdomen and tilting the patient to a reverse
Trendelenburg position, the most important observations
were increases in central aortic pressures accompanied by
an increase of augmentation index. This is in line with
previous observations reporting on an increase in mean
arterial pressure and peripheral resistance [1,2,5,9,14] after
peritoneal insufflation. To transform these results to our
observation, we have to mention that systolic central
aortic pressure increased by 10,6%, whereas augmentation
index referring to peripheral resistance increased by 66%
on average after peritoneal insufflation. It has to be noted
that hemodynamic parameters in this phase returned to
the baseline, preinduction values (Table 3). It seems that




125.17 ± 20.21 0.10
78.92 ± 16.94 0.91
44.64 ± 13.23 0.02
lood pressure
118.05 ± 19.85 0.53
81.82 ± 12.28 0.47
36.41 ± 12.60 0.13
39.15 ± 5.51 0.11
mentation
12.61 ± 7.56 0.25
31.55 ± 12.01 <0.01
137.11 ± 26.3 <0.01
Figure 1 Changes of hemodynamic parameters during the study: Means and standard deviations are shown. ӿ ӿ indicate p < 0.01,
ӿ ӿ ӿ indicate p < 0.001 compared to preinduction value; ‡ ‡ p < 0.01, ‡ ‡ indicate p < 0.001 statistical difference compared to preinsufflation value.
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http://www.biomedcentral.com/1471-2253/14/98hemodynamic depressant effects of the anesthetics sug-
gesting that changes in ASA I-II patients are clically most
probably not relevant. In a recent study, Cinnella and
co-workers also demonstrated that hemodynamic stability
after administering pneumoperitoneum is maintained
even if moderate (5 cm H2O) is applied [16].
In a previous review Wahba an co-workers [2] summa-
rized the hemodynamic effects and suggested that direct
mechanical, neurohumoral processes play a role, slightly
modified by the effect of the resorbed CO2 during pneu-
moperitoneum. Mechanical effects of pneumoperitoneum
may decrease renal flow, activating the renin-angiotensine-
aldosteron system, may result in the compression of the
abdominal veins and the aorta. It has also been proven that
inducing pneumoperitoneum leads to an increased produc-
tion of vasopressin, adrenalin, noradrenalin, renin and
cortisol, which is in correlation with the changes of mean
arterial pressure and systremic resistance [15]. According
to previous reports, this is the phase of laparoscopic chole-
cytectomy where patients of different ASA severity (ASA
I-II vs. ASA III-IV) may react differently to pneumoperito-
neum. In more severe patients (ASA III-IV) a pressure rise
in the abdomen resulted in a more pronounced increase in
mean arterial pressure and decreased oxygen delivery [17].
Consequently, left ventricular stroke work index increases,
which causes higher oxygen demand of the myocardium
[7]. In our series we included ASA I and II patients and no
subendocardial viability ratio reflecting the potential under-
perfusion of the subendocardium could be detected after
and during the course of abdominal inflation.
The principal basis of the pulse wave analysis system
is that the peripheral arterial pressure waveform may be
used for the reconstruction of central (aortic) pressure.
The method behind this is applanation tonometry, which
ensures the sensitive detection of the radial artery pulse
waveform. It is generally accepted that the characteris-
tics of the peripheral pulse reflect the changes in arterial
diameters, wall elasticity, wall thickness and the condi-
tion of the peripheral vascular beds. The main attribute
of SphygmoCor is its ability to derive the central aortic
pressure waveform non-invasively from the pressure
pulse recorded at a peripheral site, usually at the upper
arm (radial artery) [10].
Limitations
The intraoperative use of the device is limited by the pos-
ition of the radial artery, i.e. in some surgical scenarios it
may disturb the surgical team, making monitoring impos-
sible. Another limitation to be mentioned is operator-
dependency: for reliable monitoring it is necessary to have
previous experience with the technique. Finally, the main
limitation of this study is the lack of a control group,
i.e. other hemodynamic measurements were not used.
However, this trial is a pilot application of applanationtonometry in this field. As this is a non-invasive method, in
this first, pilot step of our investigations we intended to
compare hemodynamic changes with those that used inva-
sive monitoring techniques reported in the literature.
Conclusion
In conclusion: in this study we have shown that the
Sphigmocor pulse wave analysis system can be reliably
used for detecting and monitoring cardiovascular changes
occurring during laparoscopic cholecystectomy. Further
studies are needed to prove whether the method may be
helpful in delineating critical situations in patients with
limited cardiovascular reserve (ASA III-IV patients) by
defining cut-off values of safety and to help in guiding
abdominal insufflation and tilting during the procedure as
suggested in previous reports [18].
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